课题基金 / 基金详情

GLAUCOMATOUS OPTIC NERVE DAMAGE

GLAUCOMATOUS OPTIC NERVE DAMAGE
青光眼视神经损伤
批准号:
3267369
负责人:
JOHN C MORRISON
金额:
$11.71万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-04-01 至 1996-03-31

项目摘要

项目成果

JOHN C MORRISON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Glaucoma is a major cause of blindness in which optic nerve fibers die in a characteristic pattern. Although many factors may influence this process, elevated intraocular pressure (IOP) is the best documented and all glaucoma therapy is directed at controlling eye pressure. In spite of this, relatively little is known about the neuronal and glial cell response to elevated IOP, due in large part to the lack of a reliable, inexpensive animal model of pressure-induced optic nerve damage. Such a model has recently been created in rats. Selective injection of sclerosing agents into ocular surface vessels using a specially designed microneedle causes scarring of the aqueous humor outflow pathways, producing measurably increased IOP and identifiable optic nerve fiber death. This proposal will refine the technique to produce mild and severe pressure rises in separate groups of animals. The associated nerve damage will be studied using histology, automated nerve fiber counts and immunohistochemistry to demonstrate its relationship to human glaucomatous optic neuropathy. Efforts to analyze the cellular response to elevated IOP in the mammalian optic nerve and retina will begin by studying changes in protein presence and distribution using immunohistochemistry for a variety of well characterized neuronal and glial cell components, most of which have been shown to change in response to injury. Initial studies will concentrate on eyes with severe IOP elevation. Protein changes detected will then be confirmed and clarified using in situ hybridization with either synthetic oligodeoxynucleotide probes, or riboprobes, to detect evidence for cellular changes in message production. Northern blot analysis will also be used to provide semiquantitative analyses, where indicated, although their primary use will be in verifying probe specificity. Once reliable changes in specific proteins are defined in eyes with severe IOP elevation, these markers will be used to clarify the exact role of IOP in causing nerve damage by comparing eyes with mild and severe IOP elevations and comparing the effects of early versus prolonged IOP rise. These studies win serve to establish these changes as markers for future studies of the other factors that influence the glaucomatous process, how they affect optic nerve susceptibility to IOP and how they might be altered to protect the optic nerve in glaucoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mentored Vision Clinician-Scientist Program at OHSU
Mentored Vision Clinician-Scientist Program at OHSU
Ophthalmology Core Facility
Ophthalmology Core Facility
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: